Boyle A. Uniform addition of ribavirin to sofosbuvir/velpatasvir for genotype 3 patients with cirrhosis: real world outcomes. THU-285.
Associatie community-acquired fluorochinolonresistente ‘E. coli’ en gebruik van antibiotica in de omgeving
jun 2019 | Antibioticaresistentie